VitaNova Life Sciences Operating Expenses Growth & History (VNOV)
VitaNova Life Sciences's operating expenses was $906,988 for fiscal 2026.
View full VitaNova Life Sciences company overviewVitaNova Life Sciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $906,988 | $539,592 | +146.87% |
| 2025 | 2025-04-30 | $367,396 | $195,314 | +113.50% |
| 2024 | 2024-04-30 | $172,082 | $109,855 | +176.54% |
| 2023 | 2023-04-30 | $62,227 | −$71,140 | −53.34% |
| 2022 | 2022-04-30 | $133,367 | $81,273 | +156.01% |
| 2021 | 2021-04-30 | $52,094 | −$20,240 | −27.98% |
| 2020 | 2020-04-30 | $72,334 | $523 | +0.73% |
| 2019 | 2019-04-30 | $71,811 | $23,162 | +47.61% |
| 2018 | 2018-04-30 | $48,649 | — | — |
| 2017 | 2017-01-25 | $7,175 | — | — |
VitaNova Life Sciences quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $374,522 | $299,385 | +398.45% |
| Q3 2026 | 2026-01-31 | $269,612 | $189,174 | +235.18% |
| Q2 2026 | 2025-10-31 | $161,633 | $68,399 | +73.36% |
| Q1 2026 | 2025-07-31 | $101,221 | −$17,366 | −14.64% |
| Q4 2025 | 2025-04-30 | $75,137 | −$43,791 | −36.82% |
| Q3 2025 | 2025-01-31 | $80,438 | $60,286 | +299.16% |
| Q2 2025 | 2024-10-31 | $93,234 | $84,479 | +964.92% |
| Q1 2025 | 2024-07-31 | $118,587 | $94,340 | +389.08% |
| Q4 2024 | 2024-04-30 | $118,928 | $111,543 | +1510.40% |
| Q3 2024 | 2024-01-31 | $20,152 | −$14,425 | −41.72% |
| Q2 2024 | 2023-10-31 | $8,755 | $1,356 | +18.33% |
| Q1 2024 | 2023-07-31 | $24,247 | $11,381 | +88.46% |
| Q4 2023 | 2023-04-30 | $7,385 | −$64,422 | −89.72% |
| Q3 2023 | 2023-01-31 | $34,577 | $13,494 | +64.00% |
| Q2 2023 | 2022-10-31 | $7,399 | −$22,592 | −75.33% |
| Q1 2023 | 2022-07-31 | $12,866 | $2,380 | +22.70% |
| Q4 2022 | 2022-04-30 | $71,807 | $46,244 | +180.90% |
| Q3 2022 | 2022-01-31 | $21,083 | $18,184 | +627.25% |
| Q2 2022 | 2021-10-31 | $29,991 | $17,606 | +142.16% |
| Q1 2022 | 2021-07-31 | $10,486 | −$761 | −6.77% |
| Q4 2021 | 2021-04-30 | $25,563 | −$774 | −2.94% |
| Q3 2021 | 2021-01-31 | $2,899 | −$3,695 | −56.04% |
| Q2 2021 | 2020-10-31 | $12,385 | −$7,134 | −36.55% |
| Q1 2021 | 2020-07-31 | $11,247 | −$8,637 | −43.44% |
| Q4 2020 | 2020-04-30 | $26,337 | $15,108 | +134.54% |
| Q3 2020 | 2020-01-31 | $6,594 | −$30,102 | −82.03% |
| Q2 2020 | 2019-10-31 | $19,519 | $11,459 | +142.17% |
| Q1 2020 | 2019-07-31 | $19,884 | $4,058 | +25.64% |
| Q4 2019 | 2019-04-30 | $11,229 | −$17,607 | −61.06% |
| Q3 2019 | 2019-01-31 | $36,696 | $35,466 | +2883.41% |
| Q2 2019 | 2018-10-31 | $8,060 | −$4,592 | −36.29% |
| Q1 2019 | 2018-07-31 | $15,826 | $9,895 | +166.84% |
| Q4 2018 | 2018-04-30 | $28,836 | — | — |
| Q3 2018 · Jan 31 | 2018-01-31 | $1,230 | — | — |
| Q3 2018 · Oct 31 | 2017-10-31 | $12,652 | — | — |
| Q2 2018 | 2017-07-31 | $5,931 | — | — |
VitaNova Life Sciences operating expenses trends
Over the last five fiscal years, VitaNova Life Sciences's operating expenses increased from $52,094 to $906,988, a change of $854,894. The latest reported quarter, Q4 2026, shows $374,522.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review VitaNova Life Sciences source filings ↗